TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35866767

Group type: EXPERIMENTAL
Intervention: PCIA with low-dose naloxone admixture at 0.2 μg·kg‐1·h‐1 (Group B)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: PCIA with naloxone admixture at 0.4 μg·kg‐1·h‐1 (Group C)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: PCIA with naloxone admixture at 0.6 μg·kg‐1·h‐1 (Group D)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: PCIA with naloxone admixture (Group B/C/D)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (PCIA with no naloxone, Group A)
Number of subjects: 120
Study: 34407811

Group type: EXPERIMENTAL
Intervention: INT-DPM (group-based lifestyle intervention with additional support from trained volunteers)
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: INT (group-based lifestyle intervention)
Number of subjects: 432

Group type: COMPARATOR
Intervention: CON (control arm)
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: INT-DPM (in participants < 65 years old)
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: INT-DPM (in participants > 65 years old)
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: INT-DPM (with oral hypoglycaemic medication)
Number of subjects: 432
Study: 32543212

Group type: EXPERIMENTAL
Intervention: Mindfulness and modified medical yoga (MMY)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Theory (T)
Number of subjects: 20
Study: 35195738

Group type: EXPERIMENTAL
Intervention: Single carbon dioxide (CO2) laser maintenance treatment
Number of subjects: 131

Group type: COMPARATOR
Intervention: Sham treatment control group
Number of subjects: 131
Study: 34405232

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1800
Study: 32026729

Group type: EXPERIMENTAL
Intervention: CNS Vital Signs (sandbagging group)
Number of subjects: 25

Group type: COMPARATOR
Intervention: CNS Vital Signs (control group)
Number of subjects: 25
Study: 36495185

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine inhalation spray (one puff per 12 hours for 7 days)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Routine treatment alone
Number of subjects: 250
Study: 33588060

Group type: EXPERIMENTAL
Intervention: Combination group (PDT + isotretinoin 10 mg twice a day for 3 months)
Number of subjects: 70

Group type: COMPARATOR
Intervention: PDT group (PDT alone)
Number of subjects: 70
Study: 32453510

Group type: EXPERIMENTAL
Intervention: Attitude/negative messages
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Norm/positive messages
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Subjective norm
Number of subjects: 287
Study: 35272729

Group type: EXPERIMENTAL
Intervention: Electric toy car
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (gurney transport)
Number of subjects: 48
Study: 33677858

Group type: EXPERIMENTAL
Intervention: Daily cigarette smoking
Number of subjects: 5640

Group type: COMPARATOR
Intervention: Non-smokers (control group)
Number of subjects: 5640

Group type: EXPERIMENTAL
Intervention: Female smokers
Number of subjects: 5640

Group type: EXPERIMENTAL
Intervention: Male smokers
Number of subjects: 5640
Study: 32502705

Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane block with dexmedetomidine (1 μg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane block without dexmedetomidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphine intravenous patient‐controlled analgesia (Control group)
Number of subjects: 0
Study: 35959737

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate, lamivudine, and dolutegravir (TLD)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Previous regimens (not specified)
Number of subjects: 184
Study: 33843133

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy followed by pelvic re-irradiation
Number of subjects: 186

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy alone
Number of subjects: 186
Study: 34235972

Group type: EXPERIMENTAL
Intervention: Reresection within 6 weeks after initial en bloc resection
Number of subjects: 115

Group type: COMPARATOR
Intervention: Non-reresection after initial en bloc resection
Number of subjects: 115
Study: 33259482

Group type: EXPERIMENTAL
Intervention: Vitamin B12 supplementation (2 μg daily for 12 months)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Placebo (daily for 12 months)
Number of subjects: 600
Study: 34865016

Group type: EXPERIMENTAL
Intervention: Metformin 500 mg/day for 12 weeks
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 148
Study: 36271512

Group type: EXPERIMENTAL
Intervention: Torque technique
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Fanning technique
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard technique
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Torque and fanning techniques combined
Number of subjects: 160
Study: 33285652

Group type: EXPERIMENTAL
Intervention: Robot-assisted therapy (RT) for 30 minutes twice a day for 2 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional rehabilitation (CR) for 30 minutes twice a day for 2 weeks
Number of subjects: 45
Study: 616675811

Group type: EXPERIMENTAL
Intervention: Traditionally made sourdough‐leavened whole‐grain bread
Number of subjects: 0

Group type: COMPARATOR
Intervention: Industrially made white bread
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both bread types
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microbiome data
Number of subjects: 0
Study: 35385097

Group type: EXPERIMENTAL
Intervention: Single-session pain management skills intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single-session health education intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: 8 sessions of cognitive behavioral therapy
Number of subjects: 0
Study: 32251039

Group type: EXPERIMENTAL
Intervention: Nurse-led education and cardiovascular risk factor modification with motivational interviewing and electronic decision support tool, 1 face-to-face session and 4 follow-up calls over 3 months.
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (standard care).
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Nurse-led education and cardiovascular risk factor modification with motivational interviewing and electronic decision support tool.
Number of subjects: 72
Study: 35709172

Group type: EXPERIMENTAL
Intervention: OVIEW-M sperm test
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard microscope examination
Number of subjects: 200
Study: 34061332

Group type: EXPERIMENTAL
Intervention: Glass ionomer-based fissure sealant (Fuji Triage®)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Resin-based fissure sealant (Clinpro™)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Amorphous calcium phosphate-containing fissure sealant (Aegis®)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group (saliva contamination)
Number of subjects: 198
Study: 35332291

Group type: EXPERIMENTAL
Intervention: Optical coherence tomography (OCT)
Number of subjects: 626

Group type: COMPARATOR
Intervention: Slit lamp indirect ophthalmoscopy (SLIO)
Number of subjects: 626
Study: 34323164

Group type: EXPERIMENTAL
Intervention: Selinexor 60 mg twice weekly
Number of subjects: 175

Group type: COMPARATOR
Intervention: Physician’s choice (PC) treatment
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Selinexor
Number of subjects: 175
Study: 32598447

Group type: EXPERIMENTAL
Intervention: Prophylactic fat injections (3 injections according to Coleman's technique) after radiotherapy and before expander removal with definitive implant insertion.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Surgery without lipofilling (Control Group B).
Number of subjects: 60
Study: 36244120

Group type: EXPERIMENTAL
Intervention: Animal Fun program (thirty minutes, three times a week)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Standard curriculum involving general physical activity (Control)
Number of subjects: 119
Study: 34895165

Group type: EXPERIMENTAL
Intervention: Postcard-sized message (outsert)
Number of subjects: 185526

Group type: EXPERIMENTAL
Intervention: Longer narrative article (insert)
Number of subjects: 185526

Group type: COMPARATOR
Intervention: Both insert and outsert
Number of subjects: 185526

Group type: COMPARATOR
Intervention: Neither insert nor outsert
Number of subjects: 185526
Study: 33678098

Group type: EXPERIMENTAL
Intervention: Liberal fluid regime
Number of subjects: 40

Group type: COMPARATOR
Intervention: Strict fluid regime
Number of subjects: 40
Study: 32222782

Group type: EXPERIMENTAL
Intervention: Metaphor-based visual representations of pharmaceutical pollution risks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-metaphor visual representations of pharmaceutical pollution risks
Number of subjects: 20
Study: 35106315

Group type: EXPERIMENTAL
Intervention: MHAA4549A (3600 mg or 8400 mg)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: MHAA4549A
Number of subjects: 125
Study: 33865147

Group type: EXPERIMENTAL
Intervention: Auditory targeted cognitive training (TCT) for 40 hours over 16 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Computer games control condition (CG) for 40 hours over 16 weeks
Number of subjects: 43
Study: 34076981

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate combined with rituximab (HD-MTX + R)
Number of subjects: 108

Group type: COMPARATOR
Intervention: High-dose methotrexate combined with whole brain radiotherapy (WBRT)
Number of subjects: 108
Study: 36484844

Group type: EXPERIMENTAL
Intervention: piTBS
Number of subjects: 34

Group type: COMPARATOR
Intervention: iTBS
Number of subjects: 34

Group type: COMPARATOR
Intervention: sham
Number of subjects: 34
Study: 33270115

Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 10
Study: 33271112

Group type: EXPERIMENTAL
Intervention: Perioperative endocrine therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34077243

Group type: EXPERIMENTAL
Intervention: Light massage
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 104
Study: 99050129

Group type: EXPERIMENTAL
Intervention: Cocaine (80 mg/70 kg, p.o.)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: d-amphetamine (5, 10, 20 mg/70 kg, p.o.)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Caffeine (150, 300, 600 mg/70 kg, p.o.)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 32827162

Group type: EXPERIMENTAL
Intervention: Eflapegrastim (fixed dose of 13.2 mg, 3.6 mg G-CSF)
Number of subjects: 669

Group type: COMPARATOR
Intervention: Pegfilgrastim (6 mg G-CSF)
Number of subjects: 669
Study: 32421480

Group type: EXPERIMENTAL
Intervention: Sitz bath with ozonised water (Group O)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sitz bath with ordinary tap water (Group T)
Number of subjects: 80
Study: 33317434

Group type: EXPERIMENTAL
Intervention: Theory-based therapeutic approaches for treating sexual dysfunctions among CSA survivors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Empirically tested therapeutic approaches for treating sexual problems among CSA survivors
Number of subjects: 0
Study: 36414015

Group type: EXPERIMENTAL
Intervention: Video-assisted training
Number of subjects: 50

Group type: COMPARATOR
Intervention: Theoretical training
Number of subjects: 50
Study: 33598693

Group type: EXPERIMENTAL
Intervention: Midostaurin
Number of subjects: 54
Study: 32758233

Group type: EXPERIMENTAL
Intervention: IPTp delivered by community health workers (CHWs)
Number of subjects: 734

Group type: COMPARATOR
Intervention: Standard practice (IPTp delivered at health facilities)
Number of subjects: 734
Study: 35525430

Group type: EXPERIMENTAL
Intervention: 9‐valent HPV (HPV 6/11/16/18/31/33/45/52/58) competitive Luminex immunoassay
Number of subjects: 3875

Group type: COMPARATOR
Intervention: Control group (HPV DNA‒negative on day 1)
Number of subjects: 3875
Study: 33946029

Group type: EXPERIMENTAL
Intervention: Curcumin supplementation (80 mg daily for 8 weeks)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Endurance training (running on treadmill for 8 weeks, 3 sessions per week, 45-60 min per session)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Curcumin supplementation + Endurance training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no supplementation or exercise)
Number of subjects: 40
Study: 34256720

Group type: EXPERIMENTAL
Intervention: Online training course on healthy beverages standards (AB 2084)
Number of subjects: 43
Study: 34247409

Group type: EXPERIMENTAL
Intervention: Flexible dosing regimen (higher dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low dose (control)
Number of subjects: 0
Study: 32800815

Group type: EXPERIMENTAL
Intervention: Low threshold intervention (ventricular index of >p97 and anterior horn width of >6 mm)
Number of subjects: 126

Group type: COMPARATOR
Intervention: High threshold intervention (ventricular index of >p97 + 4 mm and anterior horn width of >10 mm)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Low threshold intervention
Number of subjects: 126

Group type: COMPARATOR
Intervention: High threshold intervention with ventriculoperitoneal shunt
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Low threshold intervention with ventriculoperitoneal shunt
Number of subjects: 126
Study: 36098907

Group type: EXPERIMENTAL
Intervention: Revisional Roux-en-Y gastric bypass (RYGB)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Revisional One-Anastomosis gastric bypass (OAGB)
Number of subjects: 160

Group type: COMPARATOR
Intervention: One-Anastomosis gastric bypass (OAGB)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Both groups (RYGB and OAGB)
Number of subjects: 160
Study: 33838658

Group type: EXPERIMENTAL
Intervention: Person-centered antenatal care (PCANC)
Number of subjects: 2150

Group type: COMPARATOR
Intervention: Traditional care (control group)
Number of subjects: 2150

Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 2150

Group type: EXPERIMENTAL
Intervention: Greater parity
Number of subjects: 2150

Group type: EXPERIMENTAL
Intervention: Burera district
Number of subjects: 2150
Study: 32124167

Group type: EXPERIMENTAL
Intervention: 30 randomly selected primer pairs for validation and genetic diversity study
Number of subjects: 36
Study: 35385061

Group type: EXPERIMENTAL
Intervention: Mechanochemical Ablation (MOCA)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Cyanoacrylate Adhesive (CAE)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Both MOCA and CAE
Number of subjects: 167
Study: 32522771

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy followed by surgery (Arm A): three cycles of paclitaxel and cisplatin followed by type C radical hysterectomy and pelvic ± paraaortic lymphadenectomy.
Number of subjects: 240

Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (Arm B): definitive concurrent chemoradiotherapy including external beam pelvic radiotherapy combined with concurrent weekly cisplatin followed by brachytherapy.
Number of subjects: 240
Study: 33085170

Group type: EXPERIMENTAL
Intervention: DIVAVIVA medium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Restylane Perlane Lidocaine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 0
Study: 33081788

Group type: EXPERIMENTAL
Intervention: <5% fibrosis
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: 5 to <10% fibrosis
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: ≥10% fibrosis
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Fibrosis proportion
Number of subjects: 228
Study: 35546450

Group type: EXPERIMENTAL
Intervention: Once-weekly semaglutide (n=874)
Number of subjects: 1748

Group type: COMPARATOR
Intervention: Thrice-daily insulin aspart (IAsp) (n=874)
Number of subjects: 1748

Group type: EXPERIMENTAL
Intervention: Once-weekly semaglutide
Number of subjects: 1748

Group type: COMPARATOR
Intervention: Thrice-daily insulin aspart (IAsp)
Number of subjects: 1748
Study: 33044411

Group type: EXPERIMENTAL
Intervention: Specific intervention (plasma transfusion, low‐dose unfractionated heparin, and tranexamic acid)
Number of subjects: 80
Study: 33829317

Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (therapeutic exercise only)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Comparison between HILT and Control
Number of subjects: 44
Study: 33896590

Group type: EXPERIMENTAL
Intervention: Induced normothermia (maintaining core temperature at 37°C using external cooling, cold i.v. fluids, and medications like buspirone, clonidine, and magnesium sulphate)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Induced normothermia
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (fever group)
Number of subjects: 12
Study: 36178169

Group type: EXPERIMENTAL
Intervention: High-dose green tea extract (843 mg/day EGCG)
Number of subjects: 1075
Study: 34183565

Group type: EXPERIMENTAL
Intervention: Oral estradiol 1 mg tablets
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol plus micronized progesterone (MP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Transdermal estradiol alone
Number of subjects: 20
Study: 32164631

Group type: EXPERIMENTAL
Intervention: REHIT intervention (2 sessions/week of low-intensity cycling with 'all-out' sprints, increasing from 10 to 20 seconds over 6 weeks)
Number of subjects: 25

Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: REHIT intervention
Number of subjects: 25
Study: 35567872

Group type: EXPERIMENTAL
Intervention: N. sativa oil 1000 mg/day for 8 weeks
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 44
Study: 34110902

Group type: EXPERIMENTAL
Intervention: Supervised treadmill exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 32121339

Group type: EXPERIMENTAL
Intervention: 100 g dark chocolate bar
Number of subjects: 18

Group type: COMPARATOR
Intervention: 100 g white chocolate bar
Number of subjects: 18
Study: 35554361

Group type: EXPERIMENTAL
Intervention: Neuronavigated TMS (nTMS)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Manual hotspot technique
Number of subjects: 18
Study: 32465723

Group type: COMPARATOR
Intervention: RVAD utilization in pre-approval era (N=67)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: RVAD utilization in post-approval era (N=107)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Unplanned RVAD in pre-approval era (N=67)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Unplanned RVAD in post-approval era (N=107)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Risk of CVVHD
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Post-LVAD length of stay
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: In-hospital mortality
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Post-implant survival
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Freedom from gastrointestinal bleeding
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Freedom from stroke
Number of subjects: 174
Study: 35089358

Group type: EXPERIMENTAL
Intervention: Active TMS (10-Hz transcranial magnetic stimulation) for 6 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sham TMS for 6 weeks
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Adolescents with TRD
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Adolescents with MDD
Number of subjects: 34
Study: 33507691

Group type: EXPERIMENTAL
Intervention: Curcumin + radiation therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo + radiation therapy
Number of subjects: 20
Study: 35717243

Group type: EXPERIMENTAL
Intervention: Circle of Security (COS) approach adapted to the childcare setting (COS-Classroom)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 113
Study: 35378595

Group type: EXPERIMENTAL
Intervention: Reflexology for 8 weeks
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Reflexology for 4 weeks followed by MP for 4 weeks if no response to reflexology
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: MP for 8 weeks
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: MP for 4 weeks followed by reflexology for 4 weeks if no response to MP
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Adding reflexology after the first 4 weeks of MP
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Adding either intervention compared to continuing the same one
Number of subjects: 347

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 347
Study: 34187938

Group type: EXPERIMENTAL
Intervention: LARS synthetic ligament
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (healthy men)
Number of subjects: 20
Study: 32681455

Group type: EXPERIMENTAL
Intervention: cerebellar intermittent theta burst stimulation (c‐iTBS) combined with vestibular rehabilitation (VR)
Number of subjects: 20

Group type: COMPARATOR
Intervention: sham intermittent theta burst stimulation (sham iTBS) combined with vestibular rehabilitation (VR)
Number of subjects: 20

Group type: COMPARATOR
Intervention: vestibular rehabilitation (VR)
Number of subjects: 20
Study: 34340708

Group type: EXPERIMENTAL
Intervention: 3200 IU/day oral vitamin D3 for 12 weeks
Number of subjects: 191
Study: 33160798

Group type: EXPERIMENTAL
Intervention: Immediate group (12-month weight loss program)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Delayed group (wait-list control)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Combined groups after 12 months
Number of subjects: 66
Study: 34162485

Group type: EXPERIMENTAL
Intervention: Low-dose direct acting oral anticoagulants (LDDOAC)
Number of subjects: 9360

Group type: COMPARATOR
Intervention: Warfarin (W)
Number of subjects: 9360

Group type: EXPERIMENTAL
Intervention: Dabigatran 75 mgs BID (D)
Number of subjects: 9360

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 15 mgs (R)
Number of subjects: 9360

Group type: EXPERIMENTAL
Intervention: Apixaban 2.5 mgs BID (A)
Number of subjects: 9360

Group type: EXPERIMENTAL
Intervention: Dabigatran (D)
Number of subjects: 9360

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (R)
Number of subjects: 9360

Group type: EXPERIMENTAL
Intervention: Apixaban (A)
Number of subjects: 9360